help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Griffiths, M. J.
Right arrow Articles by Evans, T. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Griffiths, M. J.
Right arrow Articles by Evans, T. W.

Am. J. Respir. Crit. Care Med., Vol 152, No. 5, 11 1995, 1599-1604.

Aminoguanidine selectively decreases cyclic GMP levels produced by inducible nitric oxide synthase

MJ Griffiths, M Messent, NP Curzen and TW Evans
Unit of Critical Care, National Heart and Lung Institute, London, United Kingdom.

Overproduction of nitric oxide (NO) following induction of NO synthase in vascular smooth muscle by endotoxin and certain cytokines contributes to the vasodilation and hyporesponsiveness to vasopressors that characterize the septic circulation. Guanosine 3',5'-cyclic monophosphate (cGMP) mediates the effects of NO in vascular smooth muscle. Vessels from animals treated with endotoxin have elevated cGMP levels compared with control animals. Aminoguanidine has been proposed as a selective inhibitor of the inducible form of NO synthase. This study compares the effects of aminoguanidine on phenylephrine-induced contractions and cGMP levels in thoracic aortic rings from endotoxin treated (20 mg/kg intraperitoneally) with sham-treated (1 ml saline intraperitoneally) rats. Endotoxin-treatment depressed phenylephrine- induced contraction and raised tissue levels of cGMP. Aminoguanidine (100 microM and 1 mM) increased phenylephrine-induced tension and decreased cGMP levels in a dose-dependent manner in intact and endothelium-denuded aortas from endotoxin-treated rats but had no effect on vessels from sham-treated rats. These findings are consistent with the hypothesis that endotoxin treatment causes increased vascular production of endothelium-independent NO, which is associated with a diminished response to vasoconstrictors. Aminoguanidine decreases indices of NO production only after endotoxin treatment, providing further evidence that it is a selective inhibitor of inducible NO synthase.


This article has been cited by other articles:


Home page
 Journal of Renin-Angiotensin-Aldosterone SystemHome page
B. Gurzu, B. Cristian Petrescu, M. Costuleanu, and G. Petrescu
Interactions between apelin and angiotensin II on rat portal vein
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2006; 7(4): 212 - 216.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
J. Yang, R. Ji, Y. Cheng, J.-Z. Sun, L. K. Jennings, and C. Zhang
L-Arginine Chlorination Results in the Formation of a Nonselective Nitric-Oxide Synthase Inhibitor
J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1044 - 1049.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
S. A. Nasraway
The Problems and Challenges of Immunotherapy in Sepsis
Chest, May 1, 2003; 123 (2009): 451S - 459S.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
K. Naoki, H. Kudo, K. Suzuki, K. Takeshita, N. Miyao, M. Ishii, N. Sato, Y. Suzuki, H. Tsumura, and K. Yamaguchi
NOS and COX isoforms and abnormal microvessel responses to CO2 and H+ in hyperoxia-injured lungs
Eur. Respir. J., July 1, 2002; 20(1): 43 - 51.
[Abstract] [Full Text] [PDF]

Home page
 Journal of Pharmacy PracticeHome page
M. I. Rudis and C. Chant
Update on Vasopressors and Inotropes in Septic Shock
Journal of Pharmacy Practice, April 1, 2002; 15(2): 124 - 134.
[Abstract] [PDF]

Home page
 Cardiovasc ResHome page
S. M. Wildhirt, S. Weismueller, C. Schulze, N. Conrad, A. Kornberg, and B. Reichart
Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury
Cardiovasc Res, August 15, 1999; 43(3): 698 - 711.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Cell Mol. Bio.Home page
K. B. Jourdan, T. W. Evans, N. J. Lamb, P. Goldstraw, and J. A. Mitchell
Autocrine Function of Inducible Nitric Oxide Synthase and Cyclooxygenase-2 in Proliferation of Human and Rat Pulmonary Artery Smooth-Muscle Cells . Species Variation
Am. J. Respir. Cell Mol. Biol., July 1, 1999; 21(1): 105 - 110.
[Abstract] [Full Text]

Home page
 Am. J. Respir. Crit. Care Med.Home page
K. SUZUKI, K. NAOKI, H. KUDO, K. NISHIO, N. SATO, T. AOKI, Y. SUZUKI, K. TAKESHITA, A. MIYATA, H. TSUMURA, et al.
Impaired Hypoxic Vasoconstriction in Intraacinar Microvasculature in Hyperoxia-exposed Rat Lungs
Am. J. Respir. Crit. Care Med., August 1, 1998; 158(2): 602 - 609.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
H. SCHÜTTE, K. MAYER, T. GESSLER, M. RÜHL, J. SCHLAUDRAFF, H. BURGER, W. SEEGER, and F. GRIMMINGER
Nitric Oxide Biosynthesis in an Exotoxin-induced Septic Lung Model . Role of cNOS and Impact on Pulmonary Hemodynamics
Am. J. Respir. Crit. Care Med., February 1, 1997; 157(2): 498 - 504.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society